LYTIX — Lytix Biopharma AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Lytix Biopharma AS, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	NAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	197	145	50.5	131	71.6
Net Total Accounts Receivable
Net Total Receivables	5.68	6.74	12.8	13.1	6.15
Prepaid Expenses
Total Other Current Assets
Total Current Assets	203	152	63.3	144	79.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.14	1.38	0.548	2.63	2.09
Other Long Term Assets
Total Assets	205	153	63.9	147	81.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.2	17.8	12.5	36.8	18.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.5	18.2	12.6	38.6	19.8
Common Stock
Additional Paid In Capital
Other Equity
Total Equity	190	135	51.3	108	61.8
Total Liabilities & Shareholders' Equity	205	153	63.9	147	81.5
Total Common Shares Outstanding